SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009734
Filing Date
2022-05-12
Accepted
2022-05-12 16:39:41
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dawn-20220331.htm   iXBRL 10-Q 2307594
2 EX-31.1 dawn-ex31_1.htm EX-31.1 15668
3 EX-31.2 dawn-ex31_2.htm EX-31.2 15710
4 EX-32.1 dawn-ex32_1.htm EX-32.1 9749
5 EX-32.2 dawn-ex32_2.htm EX-32.2 10932
6 GRAPHIC img11716408_0.jpg GRAPHIC 259204
  Complete submission text file 0000950170-22-009734.txt   8076535

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dawn-20220331_pre.xml EX-101.PRE 381409
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dawn-20220331_cal.xml EX-101.CAL 33260
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dawn-20220331_def.xml EX-101.DEF 289185
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dawn-20220331.xsd EX-101.SCH 59269
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dawn-20220331_lab.xml EX-101.LAB 450141
63 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20220331_htm.xml XML 1039204
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40431 | Film No.: 22918515
SIC: 2834 Pharmaceutical Preparations